Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505101 · ClinicalTrials.gov registry record · Phase 1
Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy
A Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use, sponsored by Florida State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT01505101: Completed Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use, sponsored by Florida State University.
NCT01505101 is a Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use that has completed, run by Florida State University. The registered enrollment target is 115 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01505101, a Phase 1 study of Chronic Pain and Opioid Abuse, Unspecified Use, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions have been shown reduce chronic pain symptoms, addictive processes, and substance use. The investigators hypothesize that relative to a support group control condition, participation in a novel mindfulness-oriented cognitive intervention, Mindfulness-Oriented Recovery Enhancement (MORE), will result in improved well-being and decreased pain, opioid craving, and opioid misuse behaviors among chronic pain patients receiving opioid therapy.
Primary Outcome
Change in pain severity, functional interference, and relief from pain treatments measured on the Brief Pain Inventory-Short Form.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness-Oriented Recovery Enhancement
- BEHAVIORAL Conventional Support Group (SG)
Study Locations (1)
Florida
- FSU College of Social Work - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-07 |
| Phase | Phase 1 |
What the finished NCT01505101 record still lists
NCT01505101 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness-Oriented Recovery Enhancement is the first listed.
NCT01505101 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT01505101 about?
NCT01505101 is a clinical study titled "Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy". Persons suffering from chronic pain who are treated with long-term opioid therapy are at risk of misusing prescription opioids and developing opioid addiction. Moreover, long-term use of opioids may result in hyperalgesia, which exacerbates opioid craving and consumption. Mindfulness interventions h...
What is the current status of trial NCT01505101?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 115 participants. The study started on 2011-10. Estimated completion is 2013-07.
What conditions does trial NCT01505101 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Abuse, Unspecified Use.
What interventions are being tested in trial NCT01505101?
The interventions under investigation include: Mindfulness-Oriented Recovery Enhancement (BEHAVIORAL), Conventional Support Group (SG) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01505101?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01505101 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01505101's enrollment target sits among peer trials
115 124th of 301 higher than 178 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Managing Chronic Tendon Pain by Metformin
RECRUITING · Phase 1
-
Optimizing Accelerated TMS for Chronic Pain With Thompson Sampling
RECRUITING · Phase 1
-
ACTION: Trial of Adding Buprenorphine, CBT, and TMS to Improve Outcomes of Long-Term Opioid Therapy for Chronic Pain
RECRUITING · Phase 1
-
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
RECRUITING · Phase 1
-
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
RECRUITING · Phase 1
-
Cognitive Behavioral Therapy for Insomnia in Chronic Pain Patients
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia